129 related articles for article (PubMed ID: 22105006)
1. [Treatment of recurrent Clostridium difficile diarrhoea using sequential therapy with vancomycin followed by rifaximin].
Zelada Rodríguez MA; Rodríguez D; Martí X; Espejo E
Rev Esp Geriatr Gerontol; 2012; 47(1):42-4. PubMed ID: 22105006
[No Abstract] [Full Text] [Related]
2. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
Berman AL
J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
[No Abstract] [Full Text] [Related]
3. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
Johnson S; Schriever C; Galang M; Kelly CP; Gerding DN
Clin Infect Dis; 2007 Mar; 44(6):846-8. PubMed ID: 17304459
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
[TBL] [Abstract][Full Text] [Related]
6. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
El-Herte RI; Baban TA; Kanj SS
Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.
Garey KW; Ghantoji SS; Shah DN; Habib M; Arora V; Jiang ZD; DuPont HL
J Antimicrob Chemother; 2011 Dec; 66(12):2850-5. PubMed ID: 21948965
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin in the treatment of recurrent Clostridium difficile infection.
Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
[TBL] [Abstract][Full Text] [Related]
9. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series.
Neff G; Zacharias V; Kaiser TE; Gaddis A; Kemmer N
Liver Transpl; 2010 Aug; 16(8):960-3. PubMed ID: 20677286
[TBL] [Abstract][Full Text] [Related]
10. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
Garey KW; Jiang ZD; Bellard A; Dupont HL
J Clin Gastroenterol; 2009 Jan; 43(1):91-3. PubMed ID: 18385603
[No Abstract] [Full Text] [Related]
11. Treating C. difficile.
Parmar MS
CMAJ; 2005 Feb; 172(4):448; author reply 448. PubMed ID: 15710921
[No Abstract] [Full Text] [Related]
12. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Huggan PJ; Murdoch DR
Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
[No Abstract] [Full Text] [Related]
13. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Bishara J; Wattad M; Paul M
Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
[No Abstract] [Full Text] [Related]
14. Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Lam SW; Bass SN; Neuner EA; Bauer SR
Int J Antimicrob Agents; 2013 Dec; 42(6):553-8. PubMed ID: 24103633
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
Gawronska A; Banasiuk M; Lachowicz D; Pituch H; Albrecht P; Banaszkiewicz A
Inflamm Bowel Dis; 2017 Dec; 23(12):2209-2214. PubMed ID: 29084080
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated disease treatment response depends on definition of cure.
Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
[No Abstract] [Full Text] [Related]
17. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
[No Abstract] [Full Text] [Related]
18. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
Oldfield EC
Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
